Acambis - Crunchbase Company Profile & Funding

Overview

Acambis

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Acambis

CB Rank

1442853

Acambis is a biotechnology company developing vaccines to treat infectious diseases in Europe and North America.

Acquired by

Sanofi Pasteur

Founded

obfuscation

Private

Cambridge, Cambridgeshire, United Kingdom

101-250

www.acambis.com

Biotechnology

Details

Operating Status

Closed

Company Type

For Profit

About the Company

Acambis plc, a biotechnology company, engages in the research, development, and manufacture of vaccines for the prevention and treatment of infectious diseases in Europe and North America. The company offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets

and travelers. Its products in pipeline also includes ChimeriVax-West Nile, a Phase II clinical trial candidate against West Nile virus and North America's endemic mosquitoborne encephalitis; and acam-flu-a, a Phase I clinical trial candidate against influenza vaccination and pandemic influenza. In addition, the company's products comprise ACAM-CdifF, a Phase I trial vaccine in clinical development against hospital-acquired infection; Herpes Simplex Virus against sexually transmitted infections; and ChimeriVax-Dengue, an advanced Phase II trial vaccine against the haemorrhagic fever. Acambis plc was formerly known as Peptide Therapeutics Group PLC and changed its name to Acambis plc in December, 2000. The company was founded in 1992 and is based in Cambridge, United Kingdom. As of September 25, 2008, Acambis plc operates as a subsidiary of Sanofi Pasteur SA.